Evidence map›Paper›PMID 22170499›Full record

ReviewAmino acids2013

Role of the mu-opioid receptor in opioid modulation of immune function.

Jana Ninković, Sabita Roy

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Amino acids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05172739 (Effect of a Perioperative Opioid Free Anaesthesia-Analgesia), which is not on this map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05172739 phase4recruitingnot on this mapstarted 2021, after this paper: background citation

Effect of a Perioperative Opioid Free Anaesthesia-Analgesia (OFA-A) Strategy on Surgical Stress Response and Immunomodulation in Elective VATS Lobectomy for NSCLC Lung Cancer: A Prospective Randomized Study

TypeinterventionalSponsorUniversity of CreteRan2021 to 2026Enrolled70ConditionsSystemic Inflammatory Response Syndrome, Postoperative Pain, Acute, Postoperative Pain, Chronic, Infections PostoperativeArmsOpioid-Based Anesthesia-Analgesia Strategy, Opioid-free Anesthesia-Analgesia Strategy
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 186 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jana NinkovićDepartment of Surgery, University of Minnesota, 420 Delaware St SE, MMC195, Minneapolis, MN 55455, USA. nink0003@umn.edu
Sabita Roy
University of Minnesota · US

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1998 to 2012
$14.0M
Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
Opioid Abuse, opportunistic infection and NeuroAIDSR01DA012104 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ROY, SABITA · 1999 to 2013
$3.7M
Morphine, HIV proteins, wound healing and InfectionR01DA022935 · NIDA · UNIVERSITY OF MINNESOTA · PI ROY, SABITA · 2007 to 2011
$1.7M
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV diR01DA031202 · NIDA · UNIVERSITY OF MINNESOTA · PI RAMAKRISHNAN, SUNDARAM, ROY, SABITA · 2011 to 2015
$1.7M
Role of Mu Opioid Receptor in Immune FunctionK02DA015349 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ROY, SABITA · 2002 to 2011
$977k
Opioid Drug abuse in the context of opportunistic infection increases susceptibilK05DA033881 · NIDA · UNIVERSITY OF MINNESOTA · PI ROY, SABITA · 2012 to 2016
$661k
Morphine and gp120 modulation of Fc gamma mediated macrophage phagocytosisF31DA026264 · NIDA · UNIVERSITY OF MINNESOTA · PI NINKOVIC, JANA · 2009 to 2010
$50k
NIDA NIH HHS 5F31-DA026264NIDA NIH HHS F31 DA026264NIDA NIH HHS K02 DA015349NIDA NIH HHS K05 DA033881NIDA NIH HHS P50 DA011806NIDA NIH HHS P50 DA11806NIDA NIH HHS R01 DA012104NIDA NIH HHS R01 DA022935NIDA NIH HHS R01 DA031202NIDA NIH HHS R01 DA12104NIDA NIH HHS T32 DA007097NIDA NIH HHS T32 DA07097
6 · The paper itself

Abstract

Endogenous opioids are synthesized in vivo to modulate pain mechanisms and inflammatory pathways. Endogenous and exogenous opioids mediate analgesia in response to painful stimuli by binding to opioid receptors on neuronal cells. However, wide distribution of opioid receptors on tissues and organ systems outside the CNS, such as the cells of the immune system, indicate that opioids are capable of exerting additional effects in the periphery, such as immunomodulation. The increased prevalence of infections in opioid abuser-based epidemiological studies further highlights the immunosuppressive effects of opioids. In spite of their many debilitating side effects, prescription opioids remain a gold standard for treatment of chronic pain. Therefore, given the prevalence of opioid use and abuse, opioid-mediated immune suppression presents a serious concern in our society today. It is imperative to understand the mechanisms by which exogenous opioids modulate immune processes. In this review, we will discuss the role of opioid receptors and their ligands in mediating immune-suppressive functions. We will summarize recent studies on direct and indirect opioid modulation of the cells of the immune system, as well as the role of opioids in exacerbation of certain disease states.

Indexed as

Analgesics, OpioidAnimalsBinding SitesHumansImmunity, CellularImmunity, InnateImmunomodulationLeukocytes, MononuclearMorphineOpioid PeptidesPainReceptors, Opioid, muSignal TransductionAnalgesics, OpioidMorphineOpioid PeptidesReceptors, Opioid, mu

Identifiers

PMID22170499
PMCPMC3912755
OpenAlexW2006027316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.